Wisconsin | 39-0971239 | |
(State of Incorporation) | (IRS Employer Identification No.) |
o | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |
o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Exhibit No. | Description of Exhibit | |
10.1
|
Brady Corporation 2005 Nonqualified Stock Option Plan for Non-Employee Directors, as amended November 20, 2008 | |
|
||
99.1
|
Press Release of Brady Corporation, dated November 20, 2008, relating to the Corporations fiscal 2009 first quarter financial results |
BRADY CORPORATION
Date: November 25, 2008
/s/ Thomas J. Felmer
Thomas J. Felmer
Senior Vice President &
Chief Financial Officer
Exhibit No.
Description of Exhibit
Brady Corporation 2005 Nonqualified Stock Option Plan for Non-Employee
Directors, as amended November 20, 2008
Press Release of Brady Corporation, dated November 20, 2008, relating to the Corporations
fiscal 2009 first quarter financial results
Years After | ||||
Date of Grant | Percentage of Shares | |||
Less than 1
|
0 | % | ||
1 but less than 2
|
33-1/3 | % | ||
2 but less than 3
|
66-2/3 | % | ||
3 or more
|
100 | % |
-2-
-3-
-4-
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(Unaudited)
Three Months Ended October 31,
2008
2007
Percentage Change
$
378,317
$
380,134
-0.5
%
197,171
192,467
2.4
%
181,146
187,667
-3.5
%
9,056
8,978
0.9
%
115,896
120,351
-3.7
%
124,952
129,329
-3.4
%
56,194
58,338
-3.7
%
1,852
118
1469.5
%
(6,361
)
(6,720
)
-5.3
%
51,685
51,736
-0.1
%
14,575
15,366
-5.1
%
$
37,110
$
36,370
2.0
%
$
0.70
$
0.67
4.5
%
$
0.69
$
0.66
4.5
%
$
0.17
$
0.15
13.3
%
$
0.68
$
0.65
4.6
%
$
0.67
$
0.64
4.7
%
$
0.15
$
0.13
15.4
%
53,291
54,350
53,938
55,121
CONSOLIDATED STATEMENTS OF CASH FLOWS
(Dollars in Thousands)
(Unaudited)
Three Months Ended
October 31
2008
2007
$
37,110
$
36,370
13,712
14,168
2,092
3,257
(198
)
46
(12,571
)
(10,880
)
(10,360
)
1,337
(8,147
)
(4,417
)
(21,679
)
(13,278
)
(3,513
)
6,086
(1,167
)
1,201
(4,721
)
33,890
(1,200
)
(5,150
)
7,860
(6,429
)
(7,395
)
1,300
(1,375
)
(5,129
)
(7,260
)
(9,061
)
(8,100
)
1,162
4,134
(1
)
(5
)
(36,508
)
667
2,712
(43,741
)
(1,259
)
(25,972
)
2,382
(79,563
)
27,753
258,355
142,846
178,792
170,599
$
9,298
$
9,298
15,605
1,782
Corporate | ||||||||||||||||||||||||
and | ||||||||||||||||||||||||
(in thousands) | Americas | Europe | Asia-Pacific | Subtotals | Eliminations | Total | ||||||||||||||||||
SALES TO EXTERNAL CUSTOMERS
|
||||||||||||||||||||||||
Three months ended:
|
||||||||||||||||||||||||
October 31, 2008
|
$ | 160,916 | $ | 108,215 | $ | 109,186 | $ | 378,317 | | $ | 378,317 | |||||||||||||
October 31, 2007
|
174,775 | 108,914 | 96,445 | 380,134 | | 380,134 | ||||||||||||||||||
|
||||||||||||||||||||||||
SALES GROWTH INFORMATION
|
||||||||||||||||||||||||
Three months ended October 31, 2008:
|
||||||||||||||||||||||||
Base
|
-8.2 | % | -5.3 | % | 11.0 | % | -2.5 | % | | -2.5 | % | |||||||||||||
Currency
|
-0.3 | % | -1.6 | % | 2.2 | % | -0.1 | % | | -0.1 | % | |||||||||||||
Acquisitions
|
0.6 | % | 6.3 | % | 0.0 | % | 2.1 | % | | 2.1 | % | |||||||||||||
Total
|
-7.9 | % | -0.6 | % | 13.2 | % | -0.5 | % | | -0.5 | % | |||||||||||||
|
||||||||||||||||||||||||
SEGMENT PROFIT (LOSS)
|
||||||||||||||||||||||||
Three months ended:
|
||||||||||||||||||||||||
October 31, 2008
|
$ | 35,524 | $ | 31,138 | $ | 22,401 | $ | 89,063 | ($2,307 | ) | $ | 86,756 | ||||||||||||
October 31, 2007
|
44,107 | $ | 29,900 | $ | 19,390 | 93,397 | ($2,237 | ) | 91,160 | |||||||||||||||
Percentage increase (decrease)
|
-19.5 | % | 4.1 | % | 15.5 | % | -4.6 | % | 3.1 | % | -4.8 | % |
Three months ended: | ||||||||
October 31, | October 31, | |||||||
2008 | 2007 | |||||||
Total profit for reportable segments
|
$ | 89,063 | $ | 93,397 | ||||
Corporate and eliminations
|
(2,307 | ) | (2,237 | ) | ||||
Unallocated amounts:
|
||||||||
Administrative costs
|
(30,562 | ) | (32,822 | ) | ||||
Investment and other income
|
1,852 | 118 | ||||||
Interest expense
|
(6,361 | ) | (6,720 | ) | ||||
|
||||||||
Income before income taxes
|
51,685 | 51,736 | ||||||
Income taxes
|
(14,575 | ) | (15,366 | ) | ||||
|
||||||||
Net income
|
$ | 37,110 | $ | 36,370 | ||||
|
Fiscal 2008 | ||||||||||||||||||||
Q1 | Q2 | Q3 | Q4 | Total | ||||||||||||||||
EBITDA (1)
|
||||||||||||||||||||
Net income
|
$ | 36,370 | $ | 36,370 | ||||||||||||||||
Interest expense
|
6,720 | 6,720 | ||||||||||||||||||
Income taxes
|
15,366 | 15,366 | ||||||||||||||||||
Depreciation and amortization
|
14,168 | 14,168 | ||||||||||||||||||
|
||||||||||||||||||||
EBITDA (non-GAAP measure)
|
$ | 72,624 | $ | | $ | | $ | | $ | 72,624 |
Fiscal 2009 | ||||||||||||||||||||
Q1 | Q2 | Q3 | Q4 | Total | ||||||||||||||||
EBITDA (1)
|
||||||||||||||||||||
Net income
|
$ | 37,110 | $ | 37,110 | ||||||||||||||||
Interest expense
|
6,361 | 6,361 | ||||||||||||||||||
Income taxes
|
14,575 | 14,575 | ||||||||||||||||||
Depreciation and amortization
|
13,712 | 13,712 | ||||||||||||||||||
|
||||||||||||||||||||
EBITDA (non-GAAP measure)
|
$ | 71,758 | $ | | $ | | $ | | $ | 71,758 |
(1) | Brady is presenting EBITDA because it is used by many of our investors and lenders, and is presented as a convenience to them. EBITDA represents net income before interest expense, income taxes and depreciation and amortization. EBITDA is not a calculation based on generally accepted accounting principles (GAAP). The amounts included in the EBITDA calculation, however, are derived from amounts included in the Condensed Consolidated Statements of Income data. EBITDA should not be considered as an alternative to net income or operating income as an indicator of the companys operating performance, or as an alternative to operating cash flows as a measure of liquidity. The EBITDA measure presented may not always be comparable to similarly titled measures reported by other companies due to differences in the components of the calculation. |